Stay updated on Primary Oral Insulin Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Primary Oral Insulin Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical-trial record for the GPPAD-POInT study is displayed, describing a completed phase 2 trial of oral insulin for type 1 diabetes prevention in genetically at-risk infants. The record includes study design, eligibility criteria, outcomes, participating locations, and publication details.
    Difference
    48%
    Check dated 2026-11-08T13:43:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-11-01T14:50:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page’s 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-25T13:57:56.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T15:14:57.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The revision label in the footer of the ClinicalTrials.gov 403 Forbidden page changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:08:04.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a minimal header and navigation, replacing the previous study record content. The additions show the 403 text, a basic header, a Home link, and a revision notice.
    Difference
    18%
    Check dated 2026-09-20T19:55:29.000Z thumbnail image

Stay in the know with updates to Primary Oral Insulin Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.